- Home
- AGRO vs IMTX Comparison
AGRO vs IMTX Comparison
Compare AGRO & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGRO | IMTX |
|---|---|---|
| Founded | 2002 | N/A |
| Country | Luxembourg | Germany |
| Employees | N/A | 407 |
| Industry | Farming/Seeds/Milling | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | AGRO | IMTX |
|---|---|---|
| Price | $10.31 | $9.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $12.80 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 822.0K | 345.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $45.90 | N/A |
| Revenue Next Year | N/A | $25.91 |
| P/E Ratio | $37.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.89 | $5.05 |
| 52 Week High | $15.89 | $12.41 |
Technical Indicators
Market Signals| Indicator | AGRO | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.83 | 40.98 |
| Support Level | $7.53 | $8.98 |
| Resistance Level | $13.86 | $10.67 |
| Average True Range (ATR) | 0.38 | 0.50 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 66.67 | 9.80 |
Price Performance
Historical ComparisonAbout AGRO Adecoagro S.A.
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.